相似文献
1
Gene therapy for heart failure: an investigational treatment that is coming of age.
Rev Esp Cardiol. 2010 Feb;63(2):137-40. doi: 10.1016/s1885-5857(10)70030-x.
2
MicroRNA therapy for the failing heart.
Circ Cardiovasc Genet. 2014 Jun;7(3):393-4. doi: 10.1161/CIRCGENETICS.114.000687.
3
Overwhelming evidence of the beneficial effects of SERCA gene transfer in heart failure.
Circ Res. 2001 Jun 8;88(11):E66-7. doi: 10.1161/hh1101.092004.
4
Heartening results: the CUPID gene therapy trial for heart failure.
Mol Ther. 2011 Jul;19(7):1181-2. doi: 10.1038/mt.2011.123.
5
Sarcoendoplasmic reticulum calcium transport ATPase 2a: a potential gene therapy target in heart failure.
Cardiol Rev. 2013 May-Jun;21(3):151-4. doi: 10.1097/CRD.0b013e3182749cdb.
6
Sarcoplasmic reticulum and calcium cycling targeting by gene therapy.
Gene Ther. 2012 Jun;19(6):596-9. doi: 10.1038/gt.2012.34. Epub 2012 May 17.
7
Design of design papers.
JACC Heart Fail. 2014 Feb;2(1):95-6. doi: 10.1016/j.jchf.2013.11.003. Epub 2014 Jan 25.
8
Cardiac calcium handling on trial: targeting the failing cardiomyocyte signalosome.
Circ Res. 2014 Jan 3;114(1):12-4. doi: 10.1161/CIRCRESAHA.113.302748.
9
Cardiac gene therapy with SERCA2a: from bench to bedside.
J Mol Cell Cardiol. 2011 May;50(5):803-12. doi: 10.1016/j.yjmcc.2010.11.011. Epub 2010 Nov 18.
10
Adenovirus gene transfer of SERCA in heart failure. A promising therapeutic approach ?
Cardiovasc Res. 2001 Feb 1;49(2):249-52. doi: 10.1016/s0008-6363(00)00275-3.
引用本文的文献
1
Current Landscape of Gene Therapy for the Treatment of Cardiovascular Disorders.
Curr Gene Ther. 2024;24(5):356-376. doi: 10.2174/0115665232268840231222035423.
Zotero 插件